Elevated expression of S100A8 and S100A9 correlates with resistance to the BCL-2 inhibitor venetoclax in AML.
Riikka KarjalainenMinxia LiuAshwini KumarLiye HeDisha MalaniAlun ParsonsMika KontroOlli KallioniemiKimmo PorkkaCaroline A HeckmanPublished in: Leukemia (2019)